QQQ   417.55 (-1.38%)
AAPL   164.95 (-1.25%)
MSFT   401.13 (-0.78%)
META   487.97 (-2.76%)
GOOGL   154.75 (-0.81%)
AMZN   176.23 (-1.67%)
TSLA   149.30 (-0.42%)
NVDA   817.98 (-3.39%)
AMD   148.63 (-4.16%)
NIO   3.83 (-4.25%)
BABA   68.70 (-0.26%)
T   16.35 (+0.12%)
F   12.12 (+0.50%)
MU   107.54 (-3.92%)
GE   149.23 (-2.43%)
CGC   7.95 (+1.53%)
DIS   111.64 (-0.70%)
AMC   3.19 (+9.25%)
PFE   25.82 (+1.69%)
PYPL   61.95 (-0.24%)
XOM   120.16 (+1.38%)
QQQ   417.55 (-1.38%)
AAPL   164.95 (-1.25%)
MSFT   401.13 (-0.78%)
META   487.97 (-2.76%)
GOOGL   154.75 (-0.81%)
AMZN   176.23 (-1.67%)
TSLA   149.30 (-0.42%)
NVDA   817.98 (-3.39%)
AMD   148.63 (-4.16%)
NIO   3.83 (-4.25%)
BABA   68.70 (-0.26%)
T   16.35 (+0.12%)
F   12.12 (+0.50%)
MU   107.54 (-3.92%)
GE   149.23 (-2.43%)
CGC   7.95 (+1.53%)
DIS   111.64 (-0.70%)
AMC   3.19 (+9.25%)
PFE   25.82 (+1.69%)
PYPL   61.95 (-0.24%)
XOM   120.16 (+1.38%)
QQQ   417.55 (-1.38%)
AAPL   164.95 (-1.25%)
MSFT   401.13 (-0.78%)
META   487.97 (-2.76%)
GOOGL   154.75 (-0.81%)
AMZN   176.23 (-1.67%)
TSLA   149.30 (-0.42%)
NVDA   817.98 (-3.39%)
AMD   148.63 (-4.16%)
NIO   3.83 (-4.25%)
BABA   68.70 (-0.26%)
T   16.35 (+0.12%)
F   12.12 (+0.50%)
MU   107.54 (-3.92%)
GE   149.23 (-2.43%)
CGC   7.95 (+1.53%)
DIS   111.64 (-0.70%)
AMC   3.19 (+9.25%)
PFE   25.82 (+1.69%)
PYPL   61.95 (-0.24%)
XOM   120.16 (+1.38%)
QQQ   417.55 (-1.38%)
AAPL   164.95 (-1.25%)
MSFT   401.13 (-0.78%)
META   487.97 (-2.76%)
GOOGL   154.75 (-0.81%)
AMZN   176.23 (-1.67%)
TSLA   149.30 (-0.42%)
NVDA   817.98 (-3.39%)
AMD   148.63 (-4.16%)
NIO   3.83 (-4.25%)
BABA   68.70 (-0.26%)
T   16.35 (+0.12%)
F   12.12 (+0.50%)
MU   107.54 (-3.92%)
GE   149.23 (-2.43%)
CGC   7.95 (+1.53%)
DIS   111.64 (-0.70%)
AMC   3.19 (+9.25%)
PFE   25.82 (+1.69%)
PYPL   61.95 (-0.24%)
XOM   120.16 (+1.38%)
Free Trial
OTCMKTS:ABCZY

Abcam (ABCZY) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free ABCZY Stock Alerts
Compare
Today's Range
N/A
50-Day Range
$19.40
▼
$19.40
52-Week Range
N/A
Volume
5,400 shs
Average Volume
4,712 shs
Market Capitalization
$3.98 billion
P/E Ratio
N/A
Dividend Yield
0.36%
Price Target
N/A
Stock Analysis
Stock Analysis
ABCZY stock logo

About Abcam Stock (OTCMKTS:ABCZY)

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Germany, the United Kingdom, and internationally. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc has partnership with Cancer Research UK for the development and commercialization of novel custom antibodies to support the acceleration of cancer research. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

ABCZY Stock News Headlines

March 18, 2024 | msn.com
Long-standing Danaher executive Markus Lusser becomes new president of Abcam
March 18, 2024 | finance.yahoo.com
Abcam appoints Markus Lusser as new President
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
November 7, 2023 | msn.com
Danaher deal for Abcam approved by 89 per cent of shareholders
November 6, 2023 | uk.news.yahoo.com
Abcam shareholders approve $5.7 billion Danaher deal
November 1, 2023 | thetimes.co.uk
Abcam founder ends fight to block takeover
October 23, 2023 | finance.yahoo.com
Leading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote "FOR" Danaher Corporation’s Proposed Acquisition of Abcam
October 21, 2023 | msn.com
Efforts to stop takeover of biotech firm Abcam dealt a blow
April 19, 2024 | InvestorPlace (Ad)
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
October 19, 2023 | msn.com
Top Abcam Investor HBK Voices Support for $5.7 Billion Sale
October 17, 2023 | stockhouse.com
Leading Proxy Advisor, ISS, Recommends Shareholders Vote "FOR" Danaher Corporation's Proposed Acquisition of Abcam
October 16, 2023 | proactiveinvestors.com
Exlusive: Why Abcam founder believes Danaher's acquisition offer falls short
October 16, 2023 | msn.com
HBK Capital Becomes Biggest Abcam Investor, Set to Support Sale
October 14, 2023 | msn.com
Abcam founder's concern over exodus of British life science companies
October 14, 2023 | msn.com
Abcam founder speaks out against growing exodus of British life science companies
October 12, 2023 | finance.yahoo.com
Independent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to Danaher
October 5, 2023 | msn.com
Abcam received multiple bids in sales process, contacted over 30 parties
October 5, 2023 | ft.com
Life sciences group Abcam rejects founder’s accusations over $5.7bn deal with Danaher
October 4, 2023 | msn.com
Abcam challenger hits out as process to set EGM date goes on
September 28, 2023 | msn.com
Abcam founder slams £4.5bn sale to US conglomerate Danaher
September 28, 2023 | ca.news.yahoo.com
UK Life Sciences Firm Abcam’s Founder Fights $5.7 Billion Bid
September 15, 2023 | msn.com
UPDATE 3-Abcam founder seeks to block $5.7 billion Danaher deal
September 15, 2023 | msn.com
Signal: Danaher’s $5.7bn acquisition of Abcam faces stand-off with founder
September 14, 2023 | finance.yahoo.com
Abcam plc Statement on Dr. Jonathan Milner’s Announcement
September 14, 2023 | thetimes.co.uk
Abcam founder Jonathan Milner renews clear-out bid
September 14, 2023 | investing.com
Abcam plc founder to vote against proposed $5.7B Danaher acquisition, believes offer undervalues the company
September 14, 2023 | finance.yahoo.com
Dr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace Board
See More Headlines
Receive ABCZY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Industrial Inorganic Chemicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:ABCZY
Previous Symbol
NASDAQ:ABCZY
CUSIP
N/A
CIK
N/A
Web
www.abcam.com
Phone
44 1223 696 000
Fax
N/A
Employees
1,492
Year Founded
1998

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$336.37 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
205,080,000
Free Float
N/A
Market Cap
$3.98 billion
Optionable
Not Optionable
Beta
1.29

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover
The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Alan Thomas Hirzel BS (Age 52)
    MS, MBA, CEO & Exec. Director
  • Mr. Michael Shaun Baldock (Age 54)
    CFO & Director
  • Dr. Jonathan Simon Milner (Age 55)
    Co-Founder & Non-Exec. Deputy Chairman
  • Mr. Mark Dermody
    Interim CIO
  • James Staveley
    VP of Investor Relations

Key Competitors

View All Competitors

ABCZY Stock Analysis - Frequently Asked Questions

Is Abcam a good dividend stock?

Abcam (OTCMKTS:ABCZY) pays an annual dividend of $0.07 per share and currently has a dividend yield of 0.36%.
Read our dividend analysis for ABCZY.

How do I buy shares of Abcam?

Shares of ABCZY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Abcam have any subsidiaries?
The following companies are subsidiares of Abcam: Abcam (US) Ltd., Abcam Trading (Shanghai) Co. Ltd., Abcam US Group Holdings Inc., and Epitomics Inc.
Read More
This page (OTCMKTS:ABCZY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Options trading has suddenly become more reliable.
Eagle Publishing